Connection
Search Results to
This is a "connection" page, showing the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.
Property | Value |
has major subject area list
|
Anti-Inflammatory Agents, Non-Steroidal; Cytochrome P-450 CYP2C9; Drug-Related Side Effects and Adverse Reactions; Pharmacogenetics; Pharmacogenomic Testing; Pharmacogenomic Variants
|
information resource reference
|
Theken KN, Lee CR, Gong L, Caudle KE, Formea CM, Gaedigk A, Klein TE, Ag?ndez JAG, Grosser T. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs. Clin Pharmacol Ther. 2020 08; 108(2):191-200.
|
label
|
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.
|